GenesisTissue Inc. is a 3D bioprinting tissue company based at the CSU Spur campus in Denver, Colorado. The biotech startup designs and manufactures personalized regenerative tissue implants for humans.
Subscribe to see GenesisTissue’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
GenesisTissue is a regenerative medicine company headquartered in United States. Its most recent funding round, Seed, closed in November 2025. Xcout tracks 1 named person at GenesisTissue, including Katie Weimer (MS, MBA CEO and Co-founder).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | Undisclosed | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of GenesisTissue's closest competitors — see the full list of competitors and alternatives →
TissueForm, Inc. is headquartered in Boulder, Colorado, and focuses on regenerative medicine and plastic surgery. The company has developed a novel biomaterial designed to address clinical problems and adapt across multiple applications.
STENTiT is a medical device spin-off company from the Eindhoven University of Technology located at the High Tech Campus in Eindhoven, focusing on the development of regenerative medical implants.
Impressio, Inc. is a medical technology company headquartered in Denver, Colorado, that develops innovative materials and medical device solutions in partnership with organizations like MedShape.
RegenMed, Inc. operates as a National Science Foundation-funded innovation ecosystem that helps regenerative medicine companies develop, grow, and scale their technologies. The organization provides resources, expertise, and collaboration opportunities to bridge industry, workforce development, and science in order to accelerate commercial applications.
Embody, Inc. is a sports medicine and medical equipment manufacturing company headquartered in Norfolk, Virginia. The company develops advanced manufacturing and regenerative technologies designed to restore peak performance for orthopedic patients.
RheumaGen, Inc. is a cell and gene therapy company based in Aurora, Colorado, engineering a new class of therapeutics to cure common and major autoimmune diseases such as celiac disease.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.